Antibody-Independent Antitumor Effects of Cd32A-Chimeric Receptor T Cells: Implications for Breast Cancer Prognosis and Treatment
Giuseppe Sconocchia(National Academies of Sciences, Engineering, and Medicine), Giulio C. Spagnoli(National Academies of Sciences, Engineering, and Medicine)
Cited by 1
Related Papers
High Myeloperoxidase Positive Cell Infiltration in Colorectal Cancer Is an Independent Favorable Prognostic Factor
|PLoS ONE|2013|110
<i>In vitro</i> elimination of epidermal growth factor receptor‐overexpressing cancer cells by CD32A‐chimeric receptor T cells in combination with cetuximab or panitumumab
|International Journal of Cancer|2019|40
Encapsulation into sterically stabilised liposomes enhances the immunogenicity of melanoma-associated Melan-A/MART-1 epitopes
|British Journal of Cancer|2004|26
CD16-158-Valine Chimeric Receptor T Cells Overcome the Resistance of KRAS-mutated Colorectal Carcinoma Cells to Cetuximab
|bioRxiv (Cold Spring Harbor Laboratory)|2019|3